Nictiazem

Nictiazem

Nictiazem is a pharmaceutical compound that belongs to the class of calcium channel blockers. It is primarily used in the management of cardiovascular conditions such as hypertension and angina pectoris. Nictiazem works by inhibiting the influx of calcium ions through L-type calcium channels, which results in the relaxation of vascular smooth muscle and a decrease in myocardial contractility.

Pharmacology

Nictiazem is a non-dihydropyridine calcium channel blocker. It selectively inhibits the transmembrane influx of calcium ions into cardiac muscle and vascular smooth muscle without affecting serum calcium concentrations. This action leads to a decrease in peripheral vascular resistance and a reduction in blood pressure.

Mechanism of Action

Nictiazem binds to the alpha-1 subunit of the L-type calcium channels located on the vascular smooth muscle and cardiac myocytes. By blocking these channels, Nictiazem reduces the intracellular calcium concentration, leading to vasodilation and decreased myocardial oxygen demand.

Pharmacokinetics

Nictiazem is well absorbed from the gastrointestinal tract, with a bioavailability of approximately 40-60% due to first-pass metabolism. It is extensively metabolized in the liver and excreted primarily in the urine. The half-life of Nictiazem is approximately 3 to 5 hours, necessitating multiple daily doses for sustained therapeutic effect.

Clinical Uses

Nictiazem is indicated for the treatment of:

• Hypertension: By reducing systemic vascular resistance, Nictiazem effectively lowers blood pressure.
• Angina Pectoris: It decreases myocardial oxygen demand and increases oxygen delivery to the heart muscle.
• Arrhythmias: Nictiazem can be used to manage certain types of arrhythmias due to its effects on cardiac conduction.

Adverse Effects

Common side effects of Nictiazem include:

• Bradycardia
• Hypotension
• Dizziness
• Headache
• Peripheral edema

Serious adverse effects may include:

• Heart failure
• Atrioventricular block

Contraindications

Nictiazem is contraindicated in patients with:

• Severe hypotension
• Advanced atrioventricular block (unless a pacemaker is present)
• Heart failure with reduced ejection fraction

Drug Interactions

Nictiazem may interact with other medications, including:

• Beta-blockers: May increase the risk of bradycardia and heart block.
• Digoxin: May increase digoxin levels, necessitating monitoring.
• CYP3A4 inhibitors: May increase Nictiazem levels and risk of toxicity.

Also see

• Calcium channel blocker
• Hypertension management
• Angina treatment
• Cardiac arrhythmia